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Abstract
In recent years, the remarkable molecular complexity of synapses has been revealed, 
with over 1,000 proteins identified in the synapse proteome. Although it is known 
that different receptors and other synaptic proteins are present in different types of 
neurons, the extent of synapse diversity across the brain is largely unknown. This 
is mainly due to the limitations of current techniques. Here, we report an efficient 
method for the purification of synaptic protein complexes, fusing a high‐affinity tag 
to endogenous PSD95 in specific cell types. We also developed a strategy, which 
enables the visualisation of endogenous PSD95 with fluorescent‐protein tag in Cre‐
recombinase‐expressing cells. We demonstrate the feasibility of proteomic analysis 
of synaptic protein complexes and visualisation of these in specific cell types. We 
find that the composition of PSD95 complexes purified from specific cell types dif-
fers from those extracted from tissues with diverse cellular composition. The results 
suggest that there might be differential interactions in the PSD95 complexes in dif-
ferent brain regions. We have detected differentially interacting proteins by compar-
ing data sets from the whole hippocampus and the CA3 subfield of the hippocampus. 
Therefore, these novel conditional PSD95 tagging lines will not only serve as pow-
erful tools for precisely dissecting synapse diversity in specific brain regions and 
subsets of neuronal cells, but also provide an opportunity to better understand brain 
region‐ and cell‐type‐specific alterations associated with various psychiatric/neuro-
logical diseases. These newly developed conditional gene tagging methods can be 
applied to many different synaptic proteins and will facilitate research on the mo-
lecular complexity of synapses.
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1 |  INTRODUCTION
Information processing in the mammalian brain depends 
on synapse proteins. Over the past two decades, proteomic 
studies have revealed remarkable synapse complexity and 
diversity. In these studies, biochemically purified protein 
complexes from the postsynaptic density were analysed 
and found to contain over 1,000 different protein compo-
nents (Bayes et al., 2012, 2017, 2011; Collins et al., 2006; 
Distler et al., 2014; Emes et al., 2008; Grant, 2007; Peng et 
al., 2004; Roy et al., 2018; Trinidad, Specht, Thalhammer, 
Schoepfer, & Burlingame, 2006; Trinidad et al., 2008; Uezu 
et al., 2016). The functional diversification of synapses is 
often related to their molecular diversity. It has been reported 
that many synaptic proteins, including different subtypes of 
receptors, isoforms of scaffolding proteins and adhesion mol-
ecules, are differentially expressed in various brain regions 
(Bayes et al., 2012, 2011; Collins et al., 2006; Emes et al., 
2008; Frank et al., 2016; Frank, Zhu, Komiyama, & Grant, 
2017; Husi, Ward, Choudhary, Blackstock, & Grant, 2000; 
Komiyama et al., 2002; Lein et al., 2007; Micheva, Busse, 
Weiler, O'Rourke, & Smith, 2010; Roy et al., 2018).
Despite this recent progress, we still have insufficient 
knowledge on precisely how individual synapses differ in 
their molecular composition and how these different types of 
synapses are distributed with regard to neuronal cell type and 
brain region. This is partly due to experimental limitations 
in accurately tracking and dissecting specific anatomical re-
gions and populations of neuronal cells. It is therefore neces-
sary to establish an experimental system that allows precise 
and reliable identification and characterisation of synapse 
diversity in vivo.
In recent years, gene targeting approaches to engi-
neer the mouse genome have proven to be a crucial tool 
for the detailed investigation of genes of interest in vivo. 
Combining gene targeting with the Cre/loxP‐recombinase 
system makes it possible to achieve the precise spatiotem-
poral control of gene expression, introduction of point 
mutations or deletions of genomic sequence. Using gene 
targeting, we have previously reported the generation of 
a constitutive PSD95‐TAP (tandem affinity purification) 
tag knock‐in mouse line (Fernandez et al., 2009), in which 
PSD95 (also known as PSD‐95 or DLG4) was in‐frame 
fused with the small peptide TAP tag, for highly efficient 
synaptic protein purifications. PSD95 is an important post-
synaptic scaffolding protein that plays key roles in synaptic 
development, protein complex assembly and plasticity. In 
the present study, we have further developed this method-
ology and now present the generation of two lines of con-
ditional knock‐in tagging mice: PSD95‐c (mCherry/eGFP; 
monomeric Cherry, enhanced green fluorescent protein) 
and PSD95‐cTAP (conditional TAP tag). In contrast to the 
global labelling of PSD95, here we applied a site‐specific 
recombination strategy that allows Cre‐mediated switching 
of fluorescent reporters that faithfully reflect endogenous 
expression. As a result, these genetically modified mice 
express red fluorescent PSD95‐mCherry prior to Cre‐me-
diated recombination and green fluorescent PSD95‐EGFP 
after recombination, thereby allowing visualisation and 
distinction of PSD95 synaptic clusters in recombined and 
non‐recombined cells. We also describe a conditional 
PSD95‐cTAP tagging line, whereby the PSD95‐TAP tag is 
expressed upon Cre‐mediated recombination, thus allow-
ing efficient isolation and purification of PSD95 protein 
complexes from recombined neurons.
Crossing these conditional tagging mice with different 
driver lines that express Cre recombinase under the con-
trol of specific types of neuronal promoters, we detected 
robust expression of PSD95‐eGFP or PSD95‐TAP in cor-
responding regions/neuronal populations. Intriguingly, we 
also detected two distinctive populations of PSD95‐posi-
tive synaptic clusters in CA1 and CA3 pyramidal neurons. 
These populations differed not only in synaptic features 
such as synaptic density, size and punctate morphology, 
but also in molecular composition of PSD95 complexes as 
revealed by proteomic analysis.
2 |  MATERIALS AND METHODS
The animal experiments described in this study were un-
dertaken under the authority of a UK Home Office Project 
Licence (PPL 70/8140) under the terms, conditions and 
regulations of the UK Home Office Animals (Scientific 
Procedures) Act 1986.
2.1 | Targeting vector construction
A previously constructed intermediate targeting vector for 
the generation of PSD95‐TAP tag mice (Fernandez et al., 
2009) was used for tagging the C‐terminus of endogenous 
PSD95 proteins. For generating the conditional fluorescent 
gene targeting vectors, a loxP‐flanked cassette containing 
red fluorescent protein mCherry coding sequence (Clontech, 
632523) and an FRT site‐flanked neomycin resistance gene 
(PGK‐neo) cassette were assembled into the backbone plas-
mid pNeoflox (Figure 1a). To generate the Cre‐mediated con-
ditional replacement of mCherry with eGFP, coding sequence 
for eGFP (Clontech, GenBank accession U55762) was further 
subcloned into the intermediate vector pNeoflox‐mCherry 
and immediately after the FRT‐PGK‐neo‐FRT‐loxP sequence 
(Figure 1a). Both mCherry and eGFP coding cassettes were 
in‐frame‐inserted just before the STOP codon of the murine 
PSD95 (Dlg4) gene using 11 amino acids encoded by nucle-
otide sequence for the loxP site as part of a flexible linker 
(Figure 1a). Approximately 4–6 kb upstream and downstream 
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regions of PSD95 last exon (with corresponding genomic 
sequence retrieved from BAC clones previously used in 
Fernandez et al., 2009) were cloned into the targeting vectors 
as 5′ and 3′ homology arms, respectively. All final targeting 
vectors contain a diphtheria toxin A (DT‐A) fragment that al-
lows for negative selection in embryonic stem cells.
The conditional PSD95‐TAP targeting vectors were de-
signed and constructed using a similar strategy to that mentioned 
F I G U R E  1  Generation of PSD95c(mCherry/eGFP) and PSD95cTAP knock‐in mice. (a) Gene targeting strategy for the PSD95c(mCherry/eGFP) mice. 
The PSD95 (Dlg4) allele was targeted with a tandem fluorescent tag (mCherry and eGFP) coding sequence inserted at the last exon and immediately 
before the STOP codon. The FRT site‐flanked neo gene was removed by crossing PSD95c(mCherry/eGFP) mice with FLPe deleter mice. The progeny 
PSD95c(mCherry/eGFP) (without neo) mice were further bred with different Cre driver lines. Bottom panel shows domain structure of PSD95‐mCherry 
fusion protein, which contains three PDZ, an SH3, a GK domain and the C‐terminal mCherry tag (before Cre recombination). Note that a short peptide 
encoded by the loxP site and a linker sequence were inserted into the open reading frame of PSD95. (b) Gene targeting strategy for the PSD95cTAP mice. 
By a similar targeting strategy, a loxP site‐flanked STOP codon and the TAP sequence were inserted before the PSD95 STOP codon. Bottom panel 
shows the domain structure of PSD95‐cTAP fusion protein (after Cre recombination), which includes the C‐terminal‐tagged TAP tag. (c) Ubiquitous 
PSD95‐mCherry/eGFP expression in adult mouse brain before (i) and after (iii) breeding with a germline CAG‐Cre driver line. Note that both PSD95‐
mCherry (identified by anti‐mCherry antibody immunostaining, i) and PSD95‐eGFP (identified by native eGFP fluorescence, iii) are widely expressed 
across the brain and show a similar distribution pattern. Scale bar: 0.5 mm. (ii) Fluorescence confocal image of brain sections of fluorescent knock‐in 
PSD95mCherry/+ mice; PSD95‐mCherry puncta (red) are located in close opposition to the anti‐Synaptophysin‐stained pre‐synaptic terminals (green; 
arrowheads). Scale bar: 2 μm. (iv) Representative image of anti‐MAP2 immunofluorescence staining on PSD95eGFP/+ brain sections. Discrete PSD95‐
eGFP puncta (green) were detected along the MAP2‐staining neuronal processes. Scale bar: 10 μm. (d) Western blotting analysis of homogenate 
extracts from wild‐type (M1, M2) and littermate heterozygous (M3, M4) PSD95mCherry/+ mice, using antibodies against murine PSD95. (e) Mean 
punctum number/100 µm2 shows that the majority of PSD95‐mCherry puncta are in close opposition to (defined as “colocalisation”) Synaptophysin‐
labelled pre‐synaptic terminals. PSD95‐mCherry and Synaptophysin‐positive puncta were manually quantified using ImageJ plugin Cell Counter (Kurt 
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above, in which the last exon of PSD95 was engineered to in‐
frame fuse to a loxP site‐flanked STOP codon, which is fol-
lowed by a short G‐S‐G linker peptide coding sequence plus 
the TAP coding sequence, which includes a histidine affinity 
tag (HAT), TEV protease cleavage site and a triple FLAG tag. 
Therefore, in the presence of Cre recombinase, the strategically 
placed STOP codon is deleted, which drives the expression of 
the in‐frame fusion protein PSD95‐TAP (Figure 1b).
2.2 | Embryonic stem (ES) cell gene 
targeting and generation of reporter mice
The targeting vectors were transfected into murine ES cells 
(E14 TG2a) via electroporation as previously described 
(Fernandez et al., 2009). G418 (300 µg/ml final concentra-
tion) was added to the ES cell culture 24  hr after plating 
for positive selection. Single G418‐resistant colonies were 
picked 5–7 days after selection.
Correctly targeted ES cell colonies were identified by 
long‐range PCR amplification (Expand Long Template PCR 
system, Roche, Cat No. 11681842001) and further injected 
into recipient blastocysts from C57BL/6J mice. Adult male 
chimaeras were selected to breed with C57BL/6J wild‐type 
female mice (The Jackson Laboratory) to produce heterozy-
gotes, which were mated with FLP deleter mice to remove 
the FRT‐flanked neo cassette. Genomic DNA extracted from 
all F1 progeny ear clips was analysed by PCR to confirm the 
genotype (data not shown).
Two lines of transgenic mice with region‐specific expres-
sion of Cre recombinase were used to establish the conditional 
reporter mouse colonies: (a) Grik4‐Cre mice expressing Cre 
recombinase in the CA3 pyramidal neurons of the hippocam-
pus (Nakazawa et al., 2002); and (b) Pvalb‐Cre mice express-
ing Cre recombinase under the control of the endogenous 
parvalbumin (Pvalb) promoter (Hippenmeyer et al., 2005).
2.3 | Histology, fluorescence 
microscopy imaging
Anaesthetised mice were transcardially perfused with 4% 
paraformaldehyde (PFA; Alfa Aesar, 30525‐89‐4) in 0.1 M 
phosphate buffer (pH 7.4). The brain was immediately post-
fixed in the same fixative (4% PFA) for 3–4 hr at 4°C be-
fore transferring into 30% (w/v) sucrose (in 0.1 M phosphate 
buffer; Sigma‐Aldrich) at 4°C for at least 24 hr. Coronal or 
sagittal sections of 18 µm thickness were cryosectioned by a 
cryostat (Thermo Fisher).
For some tissue sections, immunohistochemical stainings 
were carried out. Mounted frozen sections were thawed at room 
temperature and rehydrated with PBS for 10 min. After incubat-
ing sections with blocking solution 5% bovine serum albumin 
(BSA) in Tris‐buffered saline (pH 7.5) with 0.2% Triton X‐100 
for 2  hr at room temperature, sections were incubated with 
primary antibodies including anti‐PSD95 (mouse monoclonal 
IgG1; NeuroMab, 1:250, 75‐348), anti‐mCherry (rabbit poly-
clonal; Abcam, 1:500, ab167453), anti‐Synaptophysin (mouse 
monoclonal IgG1; Millipore, 1:250, MAB5258‐20UG), anti‐
MAP2 (rabbit polyclonal; Abcam, 1:1,000, ab32454) or anti‐
parvalbumin (mouse monoclonal IgG1; Swant, 1:200, PV235) 
in a humidified chamber overnight at 4°C. After washing three 
times, sections were incubated with Alexa Fluor 488/546/633‐
conjugated secondary antibodies (Life Technologies) for 2 hr 
at room temperature before being mounted with mounting me-
dium. Slides were imaged by a laser scanning confocal mi-
croscope (LSM510, Zeiss) using a 63× objective (NA 1.4) or 
a spinning disc confocal microscope (Andor Revolution XD 
system) with a 100× oil‐immersion Plan‐Apochromat lens 
(NA1.4). Z‐series images were collected with an optical inter-
val of 0.1 µm for 10–13 planes. Tile scans were stitched into 
larger mosaics. Images were adjusted using ImageJ (National 
Institutes of Health) or Photoshop software for visualisation 
(Adobe). For fluorescence image analysis, digital image stacks 
were analysed by ImageJ and in‐house‐designed algorithms 
written in the ImageJ macro language. Before processing, the 
original images were adjusted to subtract the background flu-
orescence intensity. All adjustments were applied equally to 
all images. Images were then subjected to the algorithms for 
punctate object segmentation and detection. Quantitative mea-
surements of punctum size and number were performed using 
an ImageJ plugin 3D Object Counter (Bolte & Cordelieres, 
2006), and statistical analyses were performed with GraphPad 
Prism 6.0 (GraphPad Software, Inc.).
2.4 | Biochemical analysis
Cervical dislocation was used as a method of animal eu-
thanasia. Whole forebrains or hippocampi dissected and 
snap‐frozen in the liquid nitrogen and kept at −80°C until 
used. Whole forebrains from the constitutively TAP‐tagged 
PSD95 line were dissected from heterozygous mice. The 
hippocampi were isolated from the conditional TAP‐tagged 
PSD95 line crossed with Grik4‐Cre mice. Single‐step affin-
ity purifications were carried out as described previously 
with minor modifications (Fernandez et al., 2009). In brief, 
brain tissue was homogenised in DOC buffer [50 mM Tris 
pH 9.0, 1% sodium deoxycholate, 50 mM NaF, 20 mM ZnCl, 
1 mM Na3VO4, 2 mM Pefabloc SC (Roche) and 1 tablet pro-
tease inhibitor cocktail/10 ml (Roche)] and clarified as de-
scribed (Grant & Husi, 2001). Extracts were incubated with 
Dynabeads coupled with FLAG antibody for 2 hr at 4°C. The 
resin was washed with three cycles of 15 resin volumes of 
DOC buffer. Captured proteins were eluted with the same 
buffer containing FLAG peptide. Eluted fractions containing 
PSD95 were pooled, concentrated in a Vivaspin concentrator 
(Vivascience), reduced with DTT, alkylated with iodoaceta-
mide and separated by one‐dimensional 4%–12% SDS‐PAGE 
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(NUPAGE, Invitrogen). The gel was fixed and stained with 
colloidal Coomassie Blue, and gel lanes were cut into slices 
and each slice was destained and digested overnight with 
trypsin (Roche, trypsin modified, sequencing grade) as re-
ported previously (Bayes et al., 2011).
Antibodies used for Western blot are FLAG Ab (anti‐
mouse, from Sigma diluted 1:1,000) and PSD95 Ab (anti‐
mouse, from Thermo, diluted 1:1,000).
2.5 | Mass spectrometry
Extracted peptides (three fractions per sample) were analysed 
by nanoLC‐MS/MS on an LTQ Orbitrap Velos (Thermo 
Fisher) hybrid mass spectrometer equipped with a nanospray 
source, coupled with an Ultimate 3000 Nano/Capillary LC 
System (Dionex). The system was controlled by Xcalibur 2.1 
(Thermo Fisher) and DCMSLink 2.08 (Dionex). Peptides 
were desalted online using a micro‐precolumn cartridge 
(C18 PepMap 100, LC Packings) and then separated using a 
120 min RP gradient (4%–32% acetonitrile/0.1% formic acid) 
on an EASY‐Spray column, 50  cm  ×  75  µm ID, PepMap 
C18, 2 µm particles, 100 Å pore size (Thermo Fisher). The 
LTQ Orbitrap Velos was operated with a cycle of one MS (in 
the Orbitrap) acquired at a resolution of 60,000 at m/z 400, 
with the ten most abundant multiple‐charged (2+ and higher) 
ions in a given chromatographic window subjected to MS/
MS fragmentation in the linear ion trap. FTMS target values 
of 3e6 and an ion trap MSn target value of 1e4 were used 
with the lock mass (445.120025) enabled. Maximum FTMS 
scan accumulation time of 500  ms and maximum ion trap 
MSn scan accumulation time of 60 ms were used. Dynamic 
exclusion was enabled with a repeat duration of 30 s with an 
exclusion list of 500 and exclusion duration of 60 s.
MS data were analysed using MaxQuant (Cox & Mann, 
2008) version 1.2.7.4. Data were searched against mouse 
UniProt sequence databases (downloaded March 2012) using 
the following search parameters: trypsin with a maximum of 
two missed cleavages, 7 ppm for MS mass tolerance, 0.5 Da 
for MS/MS mass tolerance, with acetyl (protein N‐term) and 
oxidation (M) set as variable modifications and carbami-
domethyl (C) as a fixed modification. A protein false discov-
ery rate (FDR) of 0.01 and a peptide FDR of 0.01 were used 
for identification level cut‐offs. Label‐free quantification 
was performed using MaxQuant LFQ intensities (Cox et al., 
2014), and statistical analysis was performed using Perseus 
(Tyanova et al., 2016). Only proteins quantified in at least 
three replicate purifications were included in the statistical 
analysis. Protein label‐free quantification (LFQ) intensities 
were log2‐transformed, missing values were imputed, and 
t‐testing was performed (using Perseus) with correction for 
multiple hypothesis testing using a permutation‐based FDR 
of 0.05 to identify proteins quantitatively different between 
sets of purifications.
2.6 | Gene set over‐representation analysis
In order to investigate whether any GO biological processes 
or pathways (KEGG and Panther) were enriched in the 
CA3 versus the hippocampal PSD‐95 protein complexes, 
we performed an over‐representation analysis (ORA) using 
WebGestalt (http://www.webge stalt.org/). The frequency of 
terms associated with proteins in the CA3 set was compared 
to the constitutive hippocampal set and those that were sta-
tistically over‐represented were determined with an FDR of 
0.05 (Benjamini–Hochberg).
3 |  RESULTS
3.1 | Generation and establishment of 
conditional PSD95 knock‐in tagged mice
To precisely probe the expression of endogenous PSD95 
protein, we applied a gene targeting‐based knock‐in ap-
proach in which different tags (either a TAP tag or differ-
ent fluorescent protein tags with distinct excitation/emission 
spectrums) were in‐frame‐fused to murine PSD95 (Figure 
1a,b). Previous findings have shown that the PSD95 gene 
has multiple isoforms with alternatively spliced N‐terminals 
but that all share a common C‐terminus (Bence, Arbuckle, 
Dickson, & Grant, 2005); therefore, these tags were inserted 
into the open reading frame immediately before the STOP 
codon (Figure 1a,b). To maintain the “in‐frame” insertion of 
the reporter cassettes before and after Cre‐mediated recom-
bination, we designed two similar targeting vectors for the 
fluorescent or TAP tagging, in which the mCherry coding 
sequence or a STOP codon, together with the FRT‐flanked 
selection marker cassette, was placed immediately after the 
first loxP site, which encodes 11 amino acids, plus a short 
glycine‐rich linker sequence (G‐G‐G‐S or G‐S‐G for the flu-
orescent or TAP tag, respectively; Figure 1a,b). Following 
excision of the mCherry or STOP codon sequences that re-
side between the two loxP sites, the resulting targeted allele 
will convert to the coding sequence for eGFP or TAP pep-
tide, which again follows an “in‐frame” loxP site together 
with the short glycine‐rich linker sequence (Figure 1a and 
Materials and Methods).
Over 200 G418‐resistant ES cell clones were screened, and 
correctly targeted clones were identified by long‐range PCR 
using a 3' external genomic reverse primer to validate the in-
tegrity of the targeted allele. Clones were selected for blasto-
cyst injection to generate chimaeras for either the conditional 
fluorescent tagging or TAP tagging mouse lines. Germline 
transmitted mice from chimaeras were identified by PCR ge-
notyping using specific primer sets. F1 heterozygous offspring 
were bred with FLPe deleter mice, expressing FLP recom-
binase, to remove the neo cassette flanked by two FRT sites 
(Figure 1a,b). Heterozygous progeny (without the PGK‐neo 
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cassette) were used for further breedings with either germline‐
expressing CAG‐Cre or cell‐type‐specific Cre driver lines.
To confirm that introducing fluorescent tags into the en-
dogenous gene locus did not alter the expression levels of 
endogenous PSD95, we performed Western blot analysis 
using protein extracts of homogenates from heterozygous 
PSD95mCherry/+ and littermate wild‐type mice. Antibodies 
against murine PSD95 showed two bands from the heterozy-
gous sample group, with the ~130 kDa and ~100 kDa bands 
being of similar intensity (Figure 1d).
In the absence of Cre, heterozygous PSD95c(mCherry/
eGFP)/+ mice carry a PSD95‐mCherry fusion allele, whereas 
the eGFP cassette was prevented from transcribing due to 
the downstream position of the STOP codon (Figure 1a). 
Therefore, brain sections from these mice should only be 
labelled with PSD95‐mCherry. Fluorescence microscopy of 
fixed sagittal sections from adult PSD95c(mCherry/eGFP)/+ mice 
revealed that prominent mCherry expression can be observed 
in various brain regions (Figure 1c). Higher fluorescence in-
tensity levels of PSD95‐mCherry were detected in the fore-
brain, including cerebral cortex and hippocampus, whereas 
weaker fluorescence was detected in other regions including 
the midbrain, cerebellum and medulla oblongata. Confocal 
images revealed that most of the PSD95‐mCherry puncta 
were situated in close opposition to the Synaptophysin‐im-
munoreactive pre‐synaptic terminals, thus confirming the 
synaptic localisation of PSD95‐mCherry fusion protein 
(Figure 1c‐i,ii,e). This pattern strongly resembles previous 
immunohistochemical findings using a specific PSD95 anti-
body (Fukaya & Watanabe, 2000).
Upon Cre recombination, the loxP site‐flanked region 
(including mCherry coding sequence, PGK‐neo cassette and 
the following STOP codon) was excised and the eGFP cod-
ing cassette brought immediately downstream of the PSD95 
gene, creating a PSD95‐eGFP fusion allele (Figure 1a). To 
test whether the targeted allele can be converted from PSD95‐
mCherry to PSD95‐eGFP, we crossed a male heterozygous 
PSD95c(mCherry/eGFP)/+ mouse with female CAG‐Cre trans-
genic mice (Sakai & Miyazaki, 1997). CAG‐Cre is capable of 
ubiquitous deletion of loxP site‐flanked gene sequence in the 
germline cells. As a result, brain sections from the progeny of 
these breedings should be labelled with the eGFP fluorescent 
reporter tag. As expected, breeding with the CAG‐Cre del-
eter line resulted in heterozygous mice expressing prominent 
PSD95‐eGFP across the brain (Figure 1c‐iii,iv).
3.2 | Neuronal cell‐type‐specific 
expression of PSD95‐positive synapses 
in the brain
To further examine whether the targeted allele is respon-
sive to a tissue/cell‐type‐specific conversion, conditional 
heterozygous PSD95c(mCherry/eGFP)/+ mice were bred with 
Grik4‐Cre or Pvalb‐Cre transgenic mice, respectively. 
Grik4‐Cre mice show Cre activity in nearly all pyramidal 
neurons of the hippocampal CA3 area (Akashi et al., 2009), 
whereas Pvalb‐Cre mice express Cre recombinase in par-
valbumin‐positive neurons (Hippenmeyer et al., 2005). As 
described in Figure 2a, brain cryosections from double‐
transgenic PSD95c(mCherry/eGFP)/+; Grik4‐Cre mice showed 
CA3 region‐specific expression of PSD95‐eGFP, in con-
trast to the unrecombined PSD95‐mCherry expression in 
other hippocampal regions. Interestingly, higher magnifi-
cation views revealed distinctive PSD95+ synapse popula-
tions among different hippocampal subregions: in contrast 
to the densely packed PSD95‐mCherry puncta in the CA1 
region, the PSD95‐eGFP puncta in the CA3 area (stratum 
lucidum) appeared to be larger and more sparsely distrib-
uted (Figure 2a). Quantification of PSD95 punctum density 
showed a significant difference between CA1 (~120/100 
µm2) and CA3 (~40/100 µm2) subregions (Figure 2b). 
The punctum size of PSD95 in these regions also differs 
(0.015 µm3 in CA1 vs. 0.023 µm3 in CA3; Figure 2b). 
Taken together, these data suggest that distinctive kinds of 
PSD95+ synaptic puncta occur in different subregions of 
the hippocampus.
In addition, we also examined compound PSD95c(mCherry/
eGFP)/+; Pvalb‐Cre transgenic mice. In contrast to native con-
dition, PSD95c(mCherry/eGFP)/+; Pvalb‐Cre compound mice dis-
play higher GFP fluorescence level in the cerebellum (Figure 
2a, panel iv compared to Figure 1c, panel i). Further exam-
ination of the hippocampal CA3 regions using IHC of parv-
albumin antibody to highlight parvalbumin‐positive cells has 
shown that discrete PSD95 puncta were observed distributed 
along the parvalbumin+ neuropil, suggesting a fraction of 
PSD95+ excitatory synapses identified in the hippocampal 
parvalbumin+ cells (Figure 2a, panels v and vi).
3.3 | Proteomic analysis of PSD95‐cTAP 
in the hippocampus versus the CA3 subfield
Although we have observed distinctive features of PSD95+ 
synaptic puncta from CA1 and CA3 pyramidal cells of the 
hippocampus with imaging techniques, it remains unknown 
whether and how these PSD95 complexes differ at the mo-
lecular level.
To address this issue, we performed cell‐type‐specific 
tagging of PSD95 and characterised the composition of its 
protein complexes using high‐affinity FLAG purification 
followed by analysis of complex components using mass 
spectrometry.
Mice carrying the conditional PSD95‐TAP tag alleles 
(PSD95cTAP) were crossed with the Grik4‐Cre line in which 
Cre recombinase was expressed in CA3 of the hippocampus. 
We checked the expression of tagged PSD95 protein in the 
lysates from each of the double‐transgenic lines. No leaky 
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expression of the tag could be detected in the cortex (Cx), 
hippocampus (Hp) or striatum (Str) of the PSD95cTAP/+ mice 
(Figure 3a). We could detect FLAG‐tagged PSD95 protein 
in the brain lysate from double‐transgenic mice (PSD95cTAP; 
Grik4‐Cre; Figure 3a,b).
In order to generate a robust list of PSD95 interactors in 
the hippocampus (previous data sets were generated from 
forebrain tissue; Fernandez et al., 2009), we performed four 
replicate purifications from mouse hippocampal tissue ex-
pressing the constitutively expressed TAP‐tagged version 
FIGURE 2  Fluorescence imaging of conditional PSD95 tagging mice reveals differential PSD95 synapse types in different populations of neurons. 
(a) Fluorescence imaging in the hippocampal regions of the PSD95c(mCherry/eGFP); Grik4‐Cre mice. (i) Low‐magnification view in the hippocampal region. 
Note that the CA3 subregion shows pronounced native eGFP fluorescence compared with mCherry red fluorescence in other hippocampal subregions. 
Scale bar: 0.5 mm. (ii,iii) Representative direct fluorescence images of CA1 and CA3 subregions demonstrating distinctive PSD95‐mCherry (ii) or 
PSD95‐eGFP (iii) punctum pattern in stratum lucidum and stratum radiatum, respectively. Insets are 5× magnifications of the boxed regions in the main 
images. Scale bars: 10 μm. (iv) Low‐magnification micrograph of the cerebellum in PSD95c(mCherry/eGFP); Pvalb‐Cre mice. Native eGFP fluorescence 
was detected in the molecular layer of the cerebellum, as well as the pinceau termini of basket cells. Scale bar: 0.5 mm. (v) Representative image of 
CA3 Pvalb‐positive neurons, labelled by anti‐PV235 staining (red) together with direct GFP fluorescence of PSD95‐eGFP (green). Scale bar: 10 μm. 
(vi) 5× magnification of region from v. Discrete PSD95‐eGFP puncta were detected along the Pvalb‐positive neuronal processes (arrowheads). (b) 
Quantification of PSD95 punctum density and size in CA1 and CA3 subregions of the hippocampus. Error bars: mean ± SEM; unpaired, two‐tailed t test, 
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of PSD95 (Fernandez et al., 2009) and three replicate con-
trol purifications using wild‐type mice. We then performed 
protein/peptide identification and label‐free quantification 
using MaxQuant (Cox & Mann, 2008) on all preparations. 
To define a set of proteins that were enriched in consti-
tutively expressed PSD95‐TAP purifications compared 
with control purifications, t‐testing was performed (using 
Perseus) on LFQ protein intensities with correction for mul-
tiple hypothesis testing using a permutation‐based FDR of 
0.05. Of the 403 proteins quantified in at least 3 replicates, 
103 proteins were significantly enriched in PSD95‐TAP pu-
rifications compared to controls (Figure 4a and Table S1), 
representing a data set of quantitatively enriched proteins 
associated with constitutively expressed TAP‐tagged PSD95 
in the hippocampus.
Next, we purified PSD95 complexes from hippocampi 
dissected from the PSD95cTAP; Grik4‐Cre double‐transgenic 
line (see Materials and Methods). Four replicate CA3 purifi-
cations were analysed by mass spectrometry, and we defined 
a set of proteins that were enriched in purifications from mice 
with CA3 specific expression of PSD95‐TAP by comparison 
with data from control purifications from hippocampal tissue 
of wild‐type mice. In total, of 234 proteins quantified in at 
least 3 replicates, 62 proteins were significantly enriched in 
purifications from Grik4‐Cre mice representing a data set of 
quantitatively enriched proteins associated with TAP‐tagged 
PSD95 expressed in the CA3 region of the hippocampus 
(Figure 4b and Table S2).
Comparison of the constitutive hippocampal and CA3‐
specific PSD95‐cTAP data sets reveals an overlap of 53 pro-
teins with 9 that are specific to the CA3 subfield (Figure 4c) 
and 50 that are specific to the constitutive hippocampal data 
set. The CA3 data set contains PSD95 complex components 
that are mostly (90%) independently identified as complex 
components in the hippocampus of the constitutively ex-
pressed PSD95‐TAP mouse line. Importantly, this CA3‐re-
stricted set represents just over half (51%) of the components 
of constitutive hippocampal data set, indicating that this 
approach allows the identification of brain region‐specific 
PSD95 complexes. These results demonstrate proof of con-
cept that this tagging approach allows the purification and 
characterisation of synaptic protein complexes from a spe-
cific region of the hippocampus.
In order to investigate whether PSD‐95‐associated com-
plexes in the CA3 subfield of the hippocampus might be 
functionally different to those obtained from the whole hip-
pocampus, we performed a bioinformatic analysis to identify 
GO biological processes and pathways (KEGG and Panther) 
that were over‐represented in the CA3 set compared to the 
constitutive hippocampal set (Figure S1). The CA3 PSD‐95 
set was enriched for biological processes associated with 
general synaptic functions (such as “synaptic signalling” and 
“chemical synaptic transmission”) and more specific path-
ways (such as ErbB, Rap1, ionotropic glutamate receptor and 
mAChR signalling pathways and “anterograde trans‐synaptic 
signalling”).
4 |  DISCUSSION
The findings reported here provide a proof of principle that 
conditional PSD95 labelling can be used for both visualisation 
and biochemical analysis in the mouse brain. PSD95 is one of 
the most abundant synaptic scaffolding proteins. It is widely 
expressed in many different types of neuronal cells in the 
brain and forms large macromolecular complexes with neuro-
transmitter receptors, various ion channels, cell adhesion and 
cytoskeletal proteins and signalling molecules (Collins et al., 
2006; Fernandez et al., 2009; Frank et al., 2016, 2017; Husi 
& Grant, 2001; Husi et al., 2000). These complexes play es-
sential roles in synaptic function, and mutations in the genes 
encoding the components of these complexes are implicated 
in human psychiatric disorders (Bayes et al., 2011; Kaizuka & 
Takumi, 2018). However, it is still not clear how the molecu-
lar nature of these complexes differs between brain regions 
and neuronal cell types, or at different developmental stages. 
Therefore, it was important to develop an efficient approach 
F I G U R E  3  Proteomic analysis of conditional PSD95 TAP‐
tagged mice reveals differentially interacting proteins in specific 
brain subregions. (a) Lysates from the conditionally TAP‐tagged mice 
were probed for FLAG to confirm expression of the tag. Expression 
was detected in PSD95cTAP/+;Grik4‐Cre lines (PSD95cTAP/+/Cre). 
The lysates were taken from the hippocampi of the Grik4‐Cre mice. 
No leaky expression of the tag could be detected in the cortex 
(Cx), hippocampus (Hp) or striatum (Str) of the PSD95cTAP/+ mice. 
PSD95TAP/+ mice were used as a positive control, and the tag was 
detected in all tested brain regions. (b) PSD95 expression was detected 
in all samples
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by which a reporter transgene can be activated in a tempo-
rally and spatially regulated fashion in specific cell lineage 
or tissue.
Here, we present two conditional PSD95 reporter mouse 
lines generated with a gene targeting approach. These mouse 
lines not only allow simultaneous visualisation of distinctive 
F I G U R E  4  Proteomic analysis of 
PSD95‐TAP/Grik4‐Cre complexes reveals 
a subset of the hippocampal PSD‐95 
interactome. The composition of PSD‐95 
complexes isolated from constitutive 
PSD95‐TAP and PSD95‐cTAP/Grik4‐Cre 
mice was compared to control purifications 
using label‐free quantitative mass 
spectrometry. (a) Volcano plot of proteins 
enriched in constitutive PSD95‐TAP 
purifications from hippocampal tissue versus 
wild‐type controls. A total of 103 proteins 
were significantly enriched (permutation‐
based FDR; red and green), and 53 of 
these were also enriched in PSD95‐cTAP/
Grik4‐Cre purifications (green). (b) Volcano 
plot of proteins enriched in PSD95‐cTAP/
Grik4‐Cre purifications from hippocampal 
tissue versus wild‐type controls. Sixty‐
two proteins were significantly enriched 
(permutation‐based FDR; green and blue), 
9 of which were not enriched in constitutive 
PSD95‐TAP purifications from hippocampal 
tissue (blue). (c) Venn diagram of proteins 
enriched in constitutive hippocampal PSD95 
complexes and PSD95‐cTAP/Grik4‐Cre 
complexes compared to hippocampal 
tissue controls. CA3‐restricted (Grik4‐Cre) 
PSD95 complexes are a subset of the total 
hippocampal PSD95 interactome. [Colour 
figure can be viewed at wileyonlinelibrary.
com]
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PSD95+ synaptic puncta in different populations of neurons, 
but also facilitate quantitative measurement and analysis of 
PSD95‐containing synaptic protein complexes (Frank et al., 
2016) with biochemical/proteomic methods.
A major concern with current technical efforts in molec-
ular mapping/imaging of the synapse is the use of antibodies 
that can lack sufficient specificity. Another technical diffi-
culty concerns the access of the antibody into the protein‐
dense PSD structure. In a study carried out by Fukaya and 
Watanabe (2000), processing of tissue sections with a care-
fully titrated pepsin treatment was required before specific 
labelling of PSD95 could be achieved, this involved a sub-
stantial investment of time and effort. Furthermore, antibody 
cross‐reactivity, especially when detecting closely related 
protein paralogues, also needs to be carefully considered.
Using fluorescent proteins genetically tagged to a target 
protein can overcome the above limitations. In contrast to 
conventional immunofluorescence staining or biochemical 
methods, which usually rely on antibodies, genetic tagging 
provides an easy method for direct visualisation or biochemi-
cal isolation/purification of the tagged protein.
It is also recognised that quantifying and comparing im-
munostaining signals between different brain sections is often 
difficult and unreliable, even when antibody dilution and 
staining conditions are kept consistent. In contrast, we found 
that fluorescent signals between different slices prepared 
from different individual PSD95‐eGFP knock‐in mice were 
remarkably consistent and reproducible. This has allowed us 
to survey and numerically quantify PSD95‐eGFP puncta in 
terms of their number, size and intensity at the whole brain 
scale (Zhu et al., 2018). In addition, the genetic fluorescent 
labelling makes it possible to carry out live imaging in the 
intact animal, or acute brain slices, to study the molecular dy-
namics of PSD95 (Wegner, Mott, Grant, Steffens, & Willig, 
2018).
Several lines of evidence have shown that a physiolog-
ical expression level of PSD95 is crucial for maintaining 
the normal number, size and morphology of spine synapses. 
Overexpression of PSD95 modifies synaptic transmission 
and impairs synaptic plasticity (Ehrlich & Malinow, 2004; 
El‐Husseini, Schnell, Chetkovich, Nicoll, & Bredt, 2000; 
Nikonenko et al., 2008). To precisely probe the expression of 
PSD95 and keep to a minimum the functional perturbation of 
the endogenous protein, we decided to apply a gene targeting‐
based approach. In contrast to other genetic labelling meth-
ods such as BAC transgenesis, which due to the saturation 
of targeting machinery or overexpression of labelled proteins 
may sometimes fail to report the expression and localisation 
of target protein properly, this gene targeting method enables 
tags to be integrated into a specific genomic locus. Gene 
targeting is also superior to transient transfection methods, 
which cause overexpression of the protein, and other genetic 
labelling techniques such as insertion of the LacZ reporter 
gene, which only allows a rather general evaluation of expres-
sion pattern at a cellular level (Porter, Komiyama, Vitalis, 
Kind, & Grant, 2005). In the reporter lines described in this 
study, the locus‐specific in‐frame insertion of the tag faith-
fully follows the endogenous expression of PSD95 and en-
ables precise protein localisation at the subcellular level.
One potential limitation of constitutively GFP‐tagged 
PSD95 knock‐in is difficulties in probing the expression of 
tagged protein in a specific subset of cells. The conditional 
labelling of PSD95 in this study allows not only precise vi-
sualisation, but also faithful proteomic capture and analysis 
of PSD95 molecular complexes in a specific subset of excit-
atory synapses.
Combined with appropriate Cre driver mice, these re-
porter lines offer an opportunity to readily label endoge-
nous PSD95 in selected subpopulations of neuronal cells/
tissues. For example, with the compound conditional fluo-
rescent reporter line, two distinctive populations of PSD95 
synaptic puncta from CA1 and CA3 pyramidal neurons 
identified by spectrally different fluorescent proteins were 
detected simultaneously (Figure 2b). Therefore, different 
synaptic properties (synaptic density, size and morphol-
ogy) can be readily characterised and compared at the 
single‐synapse level. Although some difficulties remain 
in terms of direct comparison of fluorescence intensity 
between two different species of fluorescent protein, the 
other conditional PSD95‐cTAP tagging line provides a key 
complementary approach.
In this study, we have also successfully isolated and 
purified PSD95 protein complexes from different brain 
regions using conditional affinity tagging methods. Our 
results suggest that there might be differential interac-
tions in the PSD95 complexes in different brain regions. 
We have detected differentially interacting proteins by 
comparing data sets from the hippocampus and the CA3 
subfield of the hippocampus. All the CA3 (PSD95‐cTAP; 
Grik4 Cre) enriched proteins (Abr, Actn4, Bai3, Cacng8, 
Grik2, Hist1h2al, Mbp, Nlgn3 and Prdx5) have been re-
ported to have important functions in brain that include 
roles in synapse formation, synaptic plasticity and psy-
chiatric disorders (Duman, Tu, & Tolias, 2016; Ge et al., 
2016; Kalinowska et al., 2015; Lanoue et al., 2013; Malty 
et al., 2017; Martinelli et al., 2016; Oh et al., 2010; Park 
et al., 2017; Sigoillot et al., 2015; Walikonis et al., 2001; 
Yamagata et al., 2017). This might indicate that different 
types of PSD95 complexes exist in different brain regions 
with distinct functions. Our initial bioinformatic analysis 
for gene enrichment suggested that there might be specific 
biological pathways, such as ErbB, Rap1, and mAChR sig-
nalling pathways and anterograde trans‐synaptic signalling, 
mediated by the proteins found in the CA3 area. However, 
a full interrogation of these data sets awaits more compre-
hensive bioinformatic analysis in the future.
   | 803ZHU et al.
The functional importance of the proteins enriched in 
PSD95 complexes in this specific brain area can be further 
elucidated by using mouse lines with conditional/floxed al-
lele for these genes crossed with same Cre driver line (e.g. 
Grik4 Cre).
We previously reported the expression pattern of PSD95 
and SynGAP, a major interactor of PSD95, in different 
brain regions and at different developmental stages (Porter 
et al., 2005). That study revealed remarkable differences in 
the expression pattern of these two PSD proteins at the cel-
lular level using lacZ reporter knock‐in mouse lines. These 
results indicated that the composition of PSD95 macromo-
lecular complexes may show a high degree of heterogeneity 
between different neuronal cells. This view is consistent 
with our current finding, which shows that the molecular 
composition of PSD95 complexes in hippocampal CA3 
neurons differs from that in the rest of the forebrain. Also, 
our recent study combining genetics and proteomics meth-
ods demonstrated that there are many different types of 
PSD95 subcomplexes in the forebrain (Frank et al., 2016), 
and our new method could help to elucidate further details 
of these different complexes. Using standardised proteomic 
analysis methods, this conditional tagging mouse line will 
enable us to accurately quantify and characterise the vari-
ous PSD95 supramolecular complexes in virtually any lin-
eage of neuronal cells/tissues with the use of different Cre 
driver lines.
In the future, we can further genetically engineer current 
reporter mouse lines (i.e. via the CRISPR/Cas system) to 
incorporate an additional fluorescent reporter gene cassette 
designed to follow a multicistronic element in order to visu-
alise target neuronal morphology. As a result, both PSD95 
and neuronal processes can be observed simultaneously upon 
Cre‐mediated recombination. Therefore, this type of reporter 
line will be a valuable tool in making useful connections be-
tween the data generated by ongoing research into the mouse 
connectome and molecular synaptome mapping.
Taken together, these novel conditional PSD95 reporter 
mouse lines will serve as a powerful tool for detailed dissec-
tion of synapse diversity in any selected subset population of 
neuronal cells/tissues via optical imaging or proteomic tech-
niques. These lines can be also used in many other research 
fields, for example the generation of transgenic animals by 
crossing with various neurological/psychiatric disease mouse 
models. Our conditional tagging method can be applied to 
any protein complexes expressed in different tissues and cell 
types in the mouse to enable the study of the distinct compo-
sition and distribution of multiprotein complexes.
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